S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
NASDAQ:CYCC

Cyclacel Pharmaceuticals News Headlines

$3.14
-0.06 (-1.88%)
(As of 01/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.05
$3.23
50-Day Range
$3.06
$4.45
52-Week Range
$2.76
$11.42
Volume
55,020 shs
Average Volume
84,162 shs
Market Capitalization
$31.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.13
Get Cyclacel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYCC and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Cyclacel Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYCC
News Sentiment

0.00

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYCC Articles
This Week

0

0

CYCC Articles
Average Week



Cyclacel Pharmaceuticals (NASDAQ:CYCC) News Headlines Today

SourceHeadline
MarketBeat logo-$0.66 EPS Expected for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) This Quarter
americanbankingnews.com - January 16 at 12:18 PM
MarketBeat logoHead to Head Analysis: Affimed (NASDAQ:AFMD) vs. Cyclacel Pharmaceuticals (NASDAQ:CYCC)
americanbankingnews.com - January 13 at 8:18 AM
seekingalpha.com logoCyclacel Pharmaceuticals reveals plans for cancer drug programs for 2022
seekingalpha.com - January 6 at 1:16 PM
finance.yahoo.com logoCyclacel Pharmaceuticals Reviews 2021 Achievements And Announces Key Business Objectives for 2022
finance.yahoo.com - January 6 at 8:13 AM
finance.yahoo.com logoCyclacel Pharmaceuticals to Participate in Biotech Showcase 2022 Virtual Conference
finance.yahoo.com - December 23 at 8:01 AM
finance.yahoo.com logoVow ASA: Vow bags USD 5.2 million cruise retrofit contract
finance.yahoo.com - December 7 at 8:44 AM
finance.yahoo.com logoCyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update
finance.yahoo.com - October 29 at 8:02 AM
finance.yahoo.com logoCyclacel Pharmaceuticals Presenting at Three Conferences in September
finance.yahoo.com - September 8 at 8:14 AM
seekingalpha.com logoCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q2 2021 Results - Earnings Call Transcript
seekingalpha.com - August 12 at 6:22 PM
nasdaq.com logoCyclacel Pharmaceuticals, Inc. Common Stock (CYCC)
nasdaq.com - August 10 at 10:21 PM
finance.yahoo.com logoCyclacel Pharmaceuticals to Release Second Quarter 2021 Financial Results and Provide Business Update
finance.yahoo.com - August 3 at 7:13 AM
nasdaq.com logoCyclacel Pharmaceuticals Convertible Exchangeable Preferred Stock About To Put More Money In Your Pocket
nasdaq.com - July 13 at 2:37 PM
finance.yahoo.com logoCyclacel Pharmaceuticals to Present at Ladenburg Thalmann’s Virtual 2021 Healthcare Conference
finance.yahoo.com - July 7 at 7:59 AM
benzinga.com logoBenzinga Insights
benzinga.com - June 6 at 6:04 PM
seekingalpha.com logoChecking In On Cyclacel Pharmaceuticals
seekingalpha.com - April 7 at 5:46 PM
finance.yahoo.com logoCyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock
finance.yahoo.com - March 11 at 6:15 PM
finance.yahoo.com logoCyclacel Pharmaceuticals Announces Presentation at 2021 BIO CEO & Investor Digital Conference
finance.yahoo.com - February 10 at 8:24 AM
msn.com logoRipster Makes The Case For Cyclacel On Benzinga's 'Power Hour'
msn.com - February 5 at 6:45 PM
msn.com logo35 Stocks Moving In Friday's Mid-Day Session
msn.com - January 15 at 2:48 PM
finance.yahoo.com logoCyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021
finance.yahoo.com - December 30 at 7:40 AM
finance.yahoo.com logoCyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures
finance.yahoo.com - December 22 at 10:51 AM
finance.yahoo.com logoCyclacel Pharmaceuticals Announces That Brian Schwartz, M.D. Was Elected to Its Board of Directors
finance.yahoo.com - December 21 at 7:46 AM
seekingalpha.com logoCyclacel Pharmaceuticals EPS misses by $1.74
seekingalpha.com - November 11 at 5:50 PM
finance.yahoo.com logoCyclacel Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - November 11 at 5:50 PM
finance.yahoo.com logoCyclacel Pharmaceuticals Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 11 at 5:50 PM
finance.yahoo.com logoCyclacel Presents Phase 1 Clinical Data Showing Safety, Anti-Tumor Activity and Good Oral Bioavailability of Fadraciclib in Patients With Advanced Solid Tumors at the EORTC-NCI-AACR Symposium 2020
finance.yahoo.com - October 26 at 9:00 AM
markets.businessinsider.com logoCyclacel Pharmaceuticals to Present at the October 2020 Lytham Partners Virtual Investor Growth Conference
markets.businessinsider.com - October 5 at 10:21 AM
finance.yahoo.com logoCyclacel Announces Fadraciclib Abstract Selected for Oral Presentation in the Late Breaking and Best Proffered Paper Session at the 32nd EORTC-NCI-AACR Symposium 2020
finance.yahoo.com - September 21 at 7:42 AM
seekingalpha.com logoCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 12 at 11:43 PM
finance.yahoo.com logoCyclacel Pharmaceuticals Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 12 at 6:42 PM
finance.yahoo.com logoCyclacel Pharmaceuticals to Release Second Quarter 2020 Financial Results
finance.yahoo.com - August 5 at 10:46 AM
www.nasdaq.com logoCyclacel (CYCC) to Report Q2 Earnings: What's in the Offing?
www.nasdaq.com - July 28 at 3:02 PM
finance.yahoo.com logoCyclacel’s Clinical Stage CDK2/9 Inhibitor Fadraciclib Targets Key Anti-Apoptotic and Oncogenic Pathways in Cancer
finance.yahoo.com - July 13 at 7:23 AM
finance.yahoo.com logoEdited Transcript of CYCC earnings conference call or presentation 12-May-20 8:30pm GMT
finance.yahoo.com - June 9 at 11:57 PM
finance.yahoo.com logo3 Biotech Stocks Under $5 With Massive Upside Potential
finance.yahoo.com - May 21 at 9:48 AM
finance.yahoo.com logoCyclacel Pharmaceuticals to Release First Quarter 2020 Financial Results
finance.yahoo.com - May 5 at 7:39 AM
www.benzinga.com logoMid-Day Market Update: TriState Capital Jumps Following Q1 Results; Cyclacel Pharmaceuticals Shares Plunge
www.benzinga.com - April 21 at 1:58 PM
finance.yahoo.com logoCompany News for Apr 21, 2020
finance.yahoo.com - April 21 at 1:58 PM
seekingalpha.com logoCyclacel plummets 52% premarket on equity offering
seekingalpha.com - April 21 at 8:58 AM
finance.yahoo.com logoCYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
finance.yahoo.com - April 21 at 8:58 AM
seekingalpha.com logoIVR, NVAX, SRG and EXEL among midday movers
seekingalpha.com - April 20 at 12:56 PM
www.benzinga.com logoMid-Day Market Update: Crude Oil Plunges 45%; Cyclacel Pharmaceuticals Shares Jump
www.benzinga.com - April 20 at 12:56 PM
markets.businessinsider.com logoStock Alert: Cyclacel Pharma Shares Up 53% In Premarket
markets.businessinsider.com - April 20 at 12:56 PM
www.benzinga.com logoNano-Cap Cyclacel Rockets Higher On Launch Of Study For Coronavirus Inflammation
www.benzinga.com - April 20 at 12:56 PM
seekingalpha.com logoCyclacel up 38% premarket on COVID-19 plan in UK
seekingalpha.com - April 20 at 7:56 AM
finance.yahoo.com logoCyclacel Pharmaceuticals Announces Collaboration With the University of Edinburgh to Study Its CDK Inhibitors to Reduce Runaway Inflammation in COVID-19 Disease
finance.yahoo.com - April 20 at 7:56 AM
finance.yahoo.com logoWhen Will Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Breakeven?
finance.yahoo.com - March 17 at 10:56 AM
seekingalpha.com logoCyclacel files for offering via Roth
seekingalpha.com - March 13 at 11:50 PM
finance.yahoo.com logoEdited Transcript of CYCC earnings conference call or presentation 26-Feb-20 9:30pm GMT
finance.yahoo.com - March 9 at 6:54 AM
www.msn.com logo50 Healthcare Stocks Moving In Friday's Pre-Market Session
www.msn.com - February 28 at 2:13 PM
Get Cyclacel Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYCC and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.